138 related articles for article (PubMed ID: 9820953)
41. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
42. Genotyping for cytochrome P450 polymorphisms.
Daly AK; King BP; Leathart JB
Methods Mol Biol; 2006; 320():193-207. PubMed ID: 16719392
[TBL] [Abstract][Full Text] [Related]
43. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.
Wormhoudt LW; Commandeur JN; Vermeulen NP
Crit Rev Toxicol; 1999 Jan; 29(1):59-124. PubMed ID: 10066160
[TBL] [Abstract][Full Text] [Related]
44. Genetic polymorphism of CYP2A6 in relation to cancer.
Kamataki T; Nunoya K; Sakai Y; Kushida H; Fujita K
Mutat Res; 1999 Jul; 428(1-2):125-30. PubMed ID: 10517986
[TBL] [Abstract][Full Text] [Related]
45. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
[TBL] [Abstract][Full Text] [Related]
46. N-acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians.
Rana SV; Sharma SK; Ola RP; Kamboj JK; Malik A; Morya RK; Sinha SK
J Clin Pharm Ther; 2014 Feb; 39(1):91-6. PubMed ID: 24188272
[TBL] [Abstract][Full Text] [Related]
47. Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene: impairment of its promoter activity.
Pitarque M; von Richter O; Oke B; Berkkan H; Oscarson M; Ingelman-Sundberg M
Biochem Biophys Res Commun; 2001 Jun; 284(2):455-60. PubMed ID: 11394901
[TBL] [Abstract][Full Text] [Related]
48. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
Sarmanová J; Benesová K; Gut I; Nedelcheva-Kristensen V; Tynková L; Soucek P
Hum Mol Genet; 2001 Jun; 10(12):1265-73. PubMed ID: 11406608
[TBL] [Abstract][Full Text] [Related]
49. Canadian Native Indians exhibit unique CYP2A6 and CYP2C19 mutant allele frequencies.
Nowak MP; Sellers EM; Tyndale RF
Clin Pharmacol Ther; 1998 Oct; 64(4):378-83. PubMed ID: 9797794
[TBL] [Abstract][Full Text] [Related]
50. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
Singla N; Gupta D; Birbian N; Singh J
Tuberculosis (Edinb); 2014 May; 94(3):293-8. PubMed ID: 24637014
[TBL] [Abstract][Full Text] [Related]
51. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations.
Inoue K; Asao T; Shimada T
Xenobiotica; 2000 Mar; 30(3):285-95. PubMed ID: 10752643
[TBL] [Abstract][Full Text] [Related]
52. Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancers.
Khlifi R; Messaoud O; Rebai A; Hamza-Chaffai A
Biomed Res Int; 2013; 2013():582768. PubMed ID: 24151610
[TBL] [Abstract][Full Text] [Related]
53. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer.
Boccia S; Cadoni G; Sayed-Tabatabaei FA; Volante M; Arzani D; De Lauretis A; Cattel C; Almadori G; van Duijn CM; Paludetti G; Ricciardi G
J Cancer Res Clin Oncol; 2008 Jan; 134(1):93-100. PubMed ID: 17611777
[TBL] [Abstract][Full Text] [Related]
54. Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.
Costa GN; Magno LA; Santana CV; Konstantinovas C; Saito ST; Machado M; Di Pietro G; Bastos-Rodrigues L; Miranda DM; De Marco LA; Romano-Silva MA; Rios-Santos F
Mol Diagn Ther; 2012 Aug; 16(4):241-50. PubMed ID: 22788240
[TBL] [Abstract][Full Text] [Related]
55. Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis.
Sun F; Chen Y; Xiang Y; Zhan S
Int J Tuberc Lung Dis; 2008 Sep; 12(9):994-1002. PubMed ID: 18713495
[TBL] [Abstract][Full Text] [Related]
56. Genetic polymorphisms of biotransformation enzymes: allele frequencies in the population of the Czech Republic.
Sarmanová J; Tynková L; Süsová S; Gut I; Soucek P
Pharmacogenetics; 2000 Dec; 10(9):781-8. PubMed ID: 11191882
[TBL] [Abstract][Full Text] [Related]
57. Polymerase chain reaction-single-strand conformation polymorphism based determination of two major genetic defects responsible for a phenotypic polymorphism of cytochrome P450 (CYP) 2C19 in the Japanese population.
Itoh K; Inoue K; Nakao H; Yanagiwara S; Tada H; Suzuki T
Anal Biochem; 2000 Aug; 284(1):160-2. PubMed ID: 10933870
[No Abstract] [Full Text] [Related]
58. Genetic analysis of the HPRT mutation of Lesch-Nyhan syndrome in a Chinese family.
Lee WJ; Lee HM; Chi CS; Yang MT; Lin HY; Lin WH
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Dec; 56(6):359-66. PubMed ID: 8851475
[TBL] [Abstract][Full Text] [Related]
59. Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma.
Tsukino H; Kuroda Y; Qiu D; Nakao H; Imai H; Katoh T
Int J Cancer; 2002 Aug; 100(4):425-8. PubMed ID: 12115524
[TBL] [Abstract][Full Text] [Related]
60. The association of endometriosis risk and genetic polymorphisms involving dioxin detoxification enzymes: a systematic review.
Guo SW
Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):134-43. PubMed ID: 16289302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]